Trial intelligence / Profile preview

Sequential chemo-immunotherapy with capecitabine, interferon alfa-2a, and IL-2 in metastatic kidney cancer

2004-002376-42Phase 2Active

Sponsor

G.O.N.O. - Gruppo Oncologico del Nord Ovest

Start

Apr 2006

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1